Source link : https://www.newshealth.biz/health-news/fda-approves-fifth-ustekinumab-biosimilar/
The US Food and Drug Administration (FDA) has approved ustekinumab-srlf (Imuldosa) as a biosimilar to ustekinumab (Stelara) for the treatment of multiple inflammatory conditions. This is the fifth ustekinumab biosimilar approved by the FDA, and it is expected to become available in the first half of 2025. Stelara, manufactured by Johnson & Johnson, has a […]
Author : News Health
Publish date : 2024-10-15 19:43:24
Copyright for syndicated content belongs to the linked Source.
inHealth